.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Chubb
Cantor Fitzgerald
Cipla
Harvard Business School
Medtronic
Teva
Argus Health
US Army
AstraZeneca

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074461

« Back to Dashboard
NDA 074461 describes INDAPAMIDE, which is a drug marketed by Amerigen Pharms Ltd, Mylan Pharms Inc, Actavis Elizabeth, Mylan, Teva, Watson Labs, Sandoz, and Ani Pharms Inc, and is included in nine NDAs. It is available from ten suppliers. Additional details are available on the INDAPAMIDE profile page.

The generic ingredient in INDAPAMIDE is indapamide. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the indapamide profile page.

Summary for NDA: 074461

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074461

Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 074461

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INDAPAMIDE
indapamide
TABLET;ORAL 074461 ANDA Mylan Pharmaceuticals Inc. 0378-0069 0378-0069-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0069-01)
INDAPAMIDE
indapamide
TABLET;ORAL 074461 ANDA Mylan Pharmaceuticals Inc. 0378-0069 0378-0069-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0069-05)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Mar 27, 1996TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1.25MG
Approval Date:Mar 26, 1997TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
US Army
Deloitte
Cipla
McKinsey
Farmers Insurance
Accenture
Federal Trade Commission
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot